Exploration of tumor growth dynamics to predict response and survival outcomes in NSCLC, including EGFR exon 20 insertion patients: A medical chart review study

The aim of this study is to explore the possibility to predict PFS and OS in NSCLC patients, including patients with EGFRex20ins, based on pre- and on-treatment tumor growth dynamics. In addition, clinical characteristics, lines of therapy, and RECIST 1.1 – based response rates (ORR) under various standards of care are characterized for patients harboring EGFRex20ins or other driver mutations and patients without driver mutations.

Lupaan tehdyt muutokset: Käsittelijöiden muuttaminen

Alkuperäisen luvan myöntäjä: Findata